Neuralink, Elon Musk‘s brain-chip startup, has achieved a major milestone with the U.S. Food and Drug Administration (FDA) granting its experimental implant, Blindsight, the “breakthrough device” designation.
This approval is a significant step forward in the company’s goal to help individuals with total or partial blindness regain their vision, even those with damaged optic nerves.
Neuralink shared the news on its X page, stating, “We have received Breakthrough Device Designation from the FDA for Blindsight. Join us in our quest to bring back sight to those who have lost it.”
The company encouraged those interested to apply to their patient registry or consider openings on their career page.
The FDA’s breakthrough device designation is reserved for medical innovations that address life-threatening conditions, fast-tracking their development and review process, according to Reuters.
Elon Musk also took to his social media platform, X, to announce the update, highlighting Blindsight’s potential to restore vision, even in severe cases.
“The Blindsight device from Neuralink will enable even those who have lost both eyes and their optic nerve to see,” Musk explained. He added that, initially, the vision might resemble low-resolution graphics similar to Atari games, but over time, it could evolve to surpass natural vision, offering capabilities like seeing infrared, ultraviolet, or radar wavelengths.
Founded by Musk in 2016, Neuralink is dedicated to creating brain-computer interfaces that can revolutionize treatments for neurological disorders.
One of its main innovations is a brain implant that interprets neural signals and wirelessly transmits them to external devices such as computers or smartphones.
As reported by Business World, Neuralink is also developing technology to help paralyzed individuals control digital devices through thought alone.
The company is currently running clinical trials with three participants to assess the effectiveness of its implants in assisting people with spinal cord injuries.
In August 2024, reports confirmed that Neuralink successfully implanted its brain-computer interface into a second patient. The patient is now able to control video games and create 3D designs solely by using their thoughts.
